Artal Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $3.39M | Buy |
|
|||||
|
2024
Q1 | $2.64M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $14.8M | Hold |
|
|||||
|
2022
Q4 | $26.2M | Hold |
|
|||||
|
2022
Q3 | $58.3M | Hold |
|
|||||
|
2022
Q2 | $64.4M | Buy |
|
|||||
|
2022
Q1 | $77.5M | Buy |
|
|||||
|
2021
Q4 | $105M | Buy |
|
|||||
|
2021
Q3 | $85.9M | Buy |
|
|||||
|
2021
Q2 | $117M | Buy |
|
|||||
|
2021
Q1 | $107M | Sell |
|
|||||
|
2020
Q4 | $127M | Sell |
|
|||||
|
2020
Q3 | $60M | Sell |
|
|||||
|
2020
Q2 | $61.8M | Sell |
|
|||||
|
2020
Q1 | $46.6M | Buy |
|
|||||
|
2019
Q4 | $39.1M | Hold |
|
|||||
|
2019
Q3 | $31.1M | Buy |
|
|||||
|
2019
Q2 | $30.4M | Sell |
|
|||||
|
2019
Q1 | $31.6M | Sell |
|
|||||
|
2018
Q4 | $27.6M | Sell |
|
|||||
|
2018
Q3 | $35.7M | Buy |
|
|||||
|
2018
Q2 | $19.3M | Buy |
|
|||||
|
2018
Q1 | $8.3M | Buy |
|